Role of janus kinase/signal transducers and activators of transcription in the pathogenesis of pancreatitis and pancreatic cancer

Gut and Liver

Volumn 6, Issue 4, 2012, Pages 417-422

  Yu, Ji Hoon ^a   Kim, Hyeyoung ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Yonsei University   (South Korea)

Author keywords

JAK STAT; Oxidative stress; Pancreatic cancer; Pancreatitis

Indexed keywords

CERULETIDE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACINAR CELL; ACUTE PANCREATITIS; APOPTOSIS; CELL PROLIFERATION; CHOLECYSTOKININ BLOOD LEVEL; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALIGNANT TRANSFORMATION; OXIDATIVE STRESS; PANCREAS CANCER; PANCREATITIS; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW;

EID: 84868145988     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2012.6.4.417     Document Type: Review

References (47)

1. Schoenberg MH, Büchler M, Gaspar M, et al. Oxygen free radicals in acute pancreatitis of the rat. Gut 1990;31:1138-1143.
2. Gough DB, Boyle B, Joyce WP, et al. Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis. Br J Surg 1990;77:1256-1259.
3. Lee JW, Seo JH, Lim JW, Kim H. Membrane proteome analysis of cerulein-stimulated pancreatic acincar cells: implication of acute pancreatitis. Gut Liver 2010;4:84-93.
4. Wisner J, Green D, Ferrell L, Renner I. Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats. Gut 1988;29:1516-1523.
5. Kim H. Inhibitory mechanism of lycopene on cytokine expression in experimental pancreatitis. Ann NY Acad Sci 2011;1229:99-102.
6. Scott P, Bruce C, Schofield D, Shiel N, Braganza JM, McCloy RF. Vitamin C status in patients with acute pancreatitis. Br J Surg 1993;80:750-754.
7. Jensen RT, Wank SA, Rowley WH, Sato S, Gardner JD. Interaction of CCK with pancreatic acinar cells. Trends Pharmacol Sci 1989;10:418-423.
8. Sato S, Stark HA, Martinez J, Beaven MA, Jensen RT, Gardner JD. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Am J Physiol 1989;257(2 Pt 1):G202-G209.
9. Gorelick FS, Adler G, Kerin HF. Cerulein-induced pancreatitis. In: Go VW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas: biology, pathobiology, and disease. 2nd ed. New York: Raven, 1993:501-526.
10. Willemer S, Elsässer HP, Adler G. Hormone-induced pancreatitis. Eur Surg Res 1992;24 Suppl 1:29-39.
11. Yu JH, Lim JW, Namkung W, Kim H, Kim KH. Suppression of cerulein-induced cytokine expression by antioxidants in pancreatic acinar cells. Lab Invest 2002;82:1359-1368.
12. Kim H. Cerulein pancreatitis: oxidative stress, inflammation, and apoptosis. Gut Liver 2008;2:74-80.
13. Yu JH, Lim JW, Kim H, Kim KH. NADPH oxidase mediates interleukin-6 expression in cerulein-stimulated pancreatic acinar cells. Int J Biochem Cell Biol 2005;37:1458-1469.
14. Jessow NW, Hay RJ. Characteristics of two rat pancreatic exocrine cell lines derived from transplantable tumors. In Vitro 1980;16:212.
15. Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998;275(6 Pt 1):C1640-C1652.
16. Chen P, Huang L, Zhang Y, Qiao M, Yao W, Yuan Y. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-kappaB activity. Int J Mol Med 2011;27:731-738.
17. Ferrand A, Kowalski-Chauvel A, Bertrand C, et al. A novel mechanism for JAK2 activation by a G protein-coupled receptor, the CCK2R: implication of this signaling pathway in pancreatic tumor models. J Biol Chem 2005;280:10710-10715.
18. Ihle JN, Witthuhn BA, Quelle FW, et al. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 1994;19:222-227.
19. Yu JH, Kim KH, Kim H. Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells. Biochem Pharmacol 2006;72:1555-1562.
20. Jatiani SS, Baker SJ, Silverman LR, Reddy EP. Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer 2010;1:979-993.
21. Gallmeier E, Schäfer C, Moubarak P, et al. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells. J Cell Physiol 2005;203:209-216.
22. Robinson K, Vona-Davis L, Riggs D, Jackson B, McFadden D. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J. J Am Coll Surg 2006;202:788-796.
23. Vona-Davis LC, Frankenberry KA, Waheed U, Peterson E, McFadden DW. Expression of STAT3 and SOCS3 in pancreatic acinar cells. J Surg Res 2005;127:14-20.
24. Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 1997;100:1853-1862.
25. Ju KD, Lim JW, Kim KH, Kim H. Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-beta1 in the pathophysiology of acute pancreatitis. Inflamm Res 2011;60:791-800.
26. Schindler C, Strehlow I. Cytokines and STAT signaling. Adv Pharmacol 2000;47:113-174.
27. Chen P, Huang L, Zhang Y, Qiao M, Yao W, Yuan Y. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity. Int J Mol Med 2011;27:731-738.
28. Frank GD, Mifune M, Inagami T, et al. Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta. Mol Cell Biol 2003;23:1581-1589.
29. David M, Romero G, Zhang ZY, Dixon JE, Larner AC. In vitro activation of the transcription factor ISGF3 by interferon alpha involves a membrane-associated tyrosine phosphatase and tyrosine kinase. J Biol Chem 1993;268:6593-6599.
30. Haque SJ, Flati V, Deb A, Williams BR. Roles of protein-tyrosine phosphatases in Stat1 alpha-mediated cell signaling. J Biol Chem 1995;270:25709-25714.
31. Lee JK, Edderkaoui M, Truong P, et al. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology 2007;133:1637-1648.
32. Simovic MO, Ballard BR, Gray KD, Stain SC. The STAT4 and STAT6 pathways in pancreatitis-associated lung injury. J Surg Res 2007;137:10-15.
33. Yu JH, Kim KH, Kim H. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. Int J Biochem Cell Biol 2008;40:677-688.
34. Yubero S, Ramudo L, Manso MA, De Dios I. Mechanisms of dexamethasone-mediated chemokine down-regulation in mild and severe acute pancreatitis. Biochim Biophys Acta 2009;1792:1205-1211.
35. Chao KC, Chao KF, Chuang CC, Liu SH. Blockade of interleukin 6 accelerates acinar cell apoptosis and attenuates experimental acute pancreatitis in vivo. Br J Surg 2006;93:332-338.
36. Ramudo L, Yubero S, Manso MA, Vicente S, De Dios I. Signal transduction of MCP-1 expression induced by pancreatitis-associated ascitic fluid in pancreatic acinar cells. J Cell Mol Med 2009;13:1314-1320.
37. Yubero S, Ramudo L, Manso MA, De Dios I. The role of redox status on chemokine expression in acute pancreatitis. Biochim Biophys Acta 2009;1792:148-154.
38. Ethridge RT, Chung DH, Slogoff M, et al. Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 2002;123:1311-1322.
39. Corcoran RB, Contino G, Deshpande V, et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res 2011;71:5020-5029.
40. Wei D, Le X, Zheng L, et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003;22:319-329.
41. Scholz A, Heinze S, Detjen KM, et al. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 2003;125:891-905.
42. Miyatsuka T, Kaneto H, Shiraiwa T, et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev 2006;20:1435-1440.
43. Lesina M, Kurkowski MU, Ludes K, et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011;19:456-469.
44. Fukuda A, Wang SC, Morris JP 4th, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011;19:441-455.
45. Tucker ON, Dannenberg AJ, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999;59:987-990.
46. Eibl G, Takata Y, Boros LG, et al. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor. Cancer Res 2005;65:982-990.
47. Dalwadi H, Krysan K, Heuze-Vourc'h N, et al. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res 2005;11:7674-7682.